Department of Chemical Engineering, Faculty of Chemical Sciences and Technologies, University of Castilla-La Mancha, 13005 Ciudad Real, Spain.
Department of Chemical Engineering and Materials, Faculty of Chemical Sciences, Complutense University of Madrid, 28040 Madrid, Spain.
Molecules. 2021 Nov 11;26(22):6813. doi: 10.3390/molecules26226813.
The inefficiency of conventional biological processes to remove pharmaceutical compounds (PhCs) in wastewater is leading to their accumulation in aquatic environments. These compounds are characterized by high toxicity, high antibiotic activity and low biodegradability, and their presence is causing serious environmental risks. Because much of the PhCs consumed by humans are excreted in the urine, hospital effluents have been considered one of the main routes of entry of PhCs into the environment. In this work, a critical review of the technologies employed for the removal of PhCs in hospital wastewater was carried out. This review provides an overview of the current state of the developed technologies for decreasing the chemical risks associated with the presence of PhCs in hospital wastewater or urine in the last years, including conventional treatments (filtration, adsorption, or biological processes), advanced oxidation processes (AOPs) and electrochemical advanced oxidation processes (EAOPs).
传统生物工艺去除废水中药物化合物(PhCs)的效率低下,导致它们在水生态环境中积累。这些化合物具有高毒性、高抗生素活性和低生物降解性,其存在造成了严重的环境风险。由于人类摄入的大部分 PhCs 都通过尿液排出,因此医院废水被认为是 PhCs 进入环境的主要途径之一。在这项工作中,对用于去除医院废水中 PhCs 的技术进行了批判性回顾。本综述概述了近年来开发的降低与医院废水中 PhCs 或尿液中存在的 PhCs 相关的化学风险的技术的现状,包括常规处理(过滤、吸附或生物工艺)、高级氧化工艺(AOPs)和电化学高级氧化工艺(EAOPs)。